Abstract
Summary
Plaque psoriasis is the most common form of psoriasis, a chronic, relapsing autoimmune skin disease characterized by red, thick patches of skin with silvery white scales.
The global Plaque Psoriasis Treatment Medications market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Plaque Psoriasis Treatment Medications include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Plaque Psoriasis Treatment Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Plaque Psoriasis Treatment Medications, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Plaque Psoriasis Treatment Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plaque Psoriasis Treatment Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Plaque Psoriasis Treatment Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Plaque Psoriasis Treatment Medications sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc.
Market Segmentation
By Company
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Organon
UCB
Segment by Type
Biologics
Small Molecule Drugs
Non-biologic Drugs
Segment by Application
Hospital
Clinic
Other
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Plaque Psoriasis Treatment Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plaque Psoriasis Treatment Medications sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Plaque Psoriasis Treatment Medications market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Plaque Psoriasis Treatment Medications include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Plaque Psoriasis Treatment Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Plaque Psoriasis Treatment Medications, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Plaque Psoriasis Treatment Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plaque Psoriasis Treatment Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Plaque Psoriasis Treatment Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Plaque Psoriasis Treatment Medications sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc.
Market Segmentation
By Company
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Organon
UCB
Segment by Type
Biologics
Small Molecule Drugs
Non-biologic Drugs
Segment by Application
Hospital
Clinic
Other
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Plaque Psoriasis Treatment Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plaque Psoriasis Treatment Medications sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Study Coverage
1.1 Plaque Psoriasis Treatment Medications Product Introduction
1.2 Market by Type
1.2.1 Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Biologics
1.2.3 Small Molecule Drugs
1.2.4 Non-biologic Drugs
1.3 Market by Application
1.3.1 Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plaque Psoriasis Treatment Medications Revenue Estimates and Forecasts 2019-2030
2.2 Global Plaque Psoriasis Treatment Medications Revenue by Region
2.2.1 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Plaque Psoriasis Treatment Medications Revenue by Region (2019-2024)
2.2.3 Global Plaque Psoriasis Treatment Medications Revenue by Region (2025-2030)
2.2.4 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2019-2030)
2.3 Global Plaque Psoriasis Treatment Medications Sales Estimates and Forecasts 2019-2030
2.4 Global Plaque Psoriasis Treatment Medications Sales by Region
2.4.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Plaque Psoriasis Treatment Medications Sales by Region (2019-2024)
2.4.3 Global Plaque Psoriasis Treatment Medications Sales by Region (2025-2030)
2.4.4 Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers
3.1.1 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (2019-2024)
3.1.2 Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plaque Psoriasis Treatment Medications in 2023
3.2 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers
3.2.1 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (2019-2024)
3.2.2 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Plaque Psoriasis Treatment Medications Revenue in 2023
3.3 Global Key Players of Plaque Psoriasis Treatment Medications, Industry Ranking, 2021 VS 2022
3.4 Global Plaque Psoriasis Treatment Medications Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Plaque Psoriasis Treatment Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Product Offered and Application
3.8 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plaque Psoriasis Treatment Medications Sales by Type
4.1.1 Global Plaque Psoriasis Treatment Medications Historical Sales by Type (2019-2024)
4.1.2 Global Plaque Psoriasis Treatment Medications Forecasted Sales by Type (2025-2030)
4.1.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2019-2030)
4.2 Global Plaque Psoriasis Treatment Medications Revenue by Type
4.2.1 Global Plaque Psoriasis Treatment Medications Historical Revenue by Type (2019-2024)
4.2.2 Global Plaque Psoriasis Treatment Medications Forecasted Revenue by Type (2025-2030)
4.2.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2019-2030)
4.3 Global Plaque Psoriasis Treatment Medications Price by Type
4.3.1 Global Plaque Psoriasis Treatment Medications Price by Type (2019-2024)
4.3.2 Global Plaque Psoriasis Treatment Medications Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Plaque Psoriasis Treatment Medications Sales by Application
5.1.1 Global Plaque Psoriasis Treatment Medications Historical Sales by Application (2019-2024)
5.1.2 Global Plaque Psoriasis Treatment Medications Forecasted Sales by Application (2025-2030)
5.1.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2019-2030)
5.2 Global Plaque Psoriasis Treatment Medications Revenue by Application
5.2.1 Global Plaque Psoriasis Treatment Medications Historical Revenue by Application (2019-2024)
5.2.2 Global Plaque Psoriasis Treatment Medications Forecasted Revenue by Application (2025-2030)
5.2.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2019-2030)
5.3 Global Plaque Psoriasis Treatment Medications Price by Application
5.3.1 Global Plaque Psoriasis Treatment Medications Price by Application (2019-2024)
5.3.2 Global Plaque Psoriasis Treatment Medications Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Plaque Psoriasis Treatment Medications Market Size by Type
6.1.1 US & Canada Plaque Psoriasis Treatment Medications Sales by Type (2019-2030)
6.1.2 US & Canada Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030)
6.2 US & Canada Plaque Psoriasis Treatment Medications Market Size by Application
6.2.1 US & Canada Plaque Psoriasis Treatment Medications Sales by Application (2019-2030)
6.2.2 US & Canada Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030)
6.3 US & Canada Plaque Psoriasis Treatment Medications Market Size by Country
6.3.1 US & Canada Plaque Psoriasis Treatment Medications Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Plaque Psoriasis Treatment Medications Revenue by Country (2019-2030)
6.3.3 US & Canada Plaque Psoriasis Treatment Medications Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Plaque Psoriasis Treatment Medications Market Size by Type
7.1.1 Europe Plaque Psoriasis Treatment Medications Sales by Type (2019-2030)
7.1.2 Europe Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030)
7.2 Europe Plaque Psoriasis Treatment Medications Market Size by Application
7.2.1 Europe Plaque Psoriasis Treatment Medications Sales by Application (2019-2030)
7.2.2 Europe Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030)
7.3 Europe Plaque Psoriasis Treatment Medications Market Size by Country
7.3.1 Europe Plaque Psoriasis Treatment Medications Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Plaque Psoriasis Treatment Medications Revenue by Country (2019-2030)
7.3.3 Europe Plaque Psoriasis Treatment Medications Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Plaque Psoriasis Treatment Medications Market Size by Type
8.1.1 China Plaque Psoriasis Treatment Medications Sales by Type (2019-2030)
8.1.2 China Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030)
8.2 China Plaque Psoriasis Treatment Medications Market Size by Application
8.2.1 China Plaque Psoriasis Treatment Medications Sales by Application (2019-2030)
8.2.2 China Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Plaque Psoriasis Treatment Medications Market Size by Type
9.1.1 Asia Plaque Psoriasis Treatment Medications Sales by Type (2019-2030)
9.1.2 Asia Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030)
9.2 Asia Plaque Psoriasis Treatment Medications Market Size by Application
9.2.1 Asia Plaque Psoriasis Treatment Medications Sales by Application (2019-2030)
9.2.2 Asia Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030)
9.3 Asia Plaque Psoriasis Treatment Medications Market Size by Region
9.3.1 Asia Plaque Psoriasis Treatment Medications Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Plaque Psoriasis Treatment Medications Revenue by Region (2019-2030)
9.3.3 Asia Plaque Psoriasis Treatment Medications Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Market Size by Type
10.1.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Market Size by Application
10.2.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Market Size by Country
10.3.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Overview
11.1.3 Amgen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Amgen Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Overview
11.2.3 Allergan Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Allergan Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Dermira
11.3.1 Dermira Company Information
11.3.2 Dermira Overview
11.3.3 Dermira Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Dermira Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dermira Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Novartis Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Overview
11.6.3 Merck Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Merck Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Pfizer Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Overview
11.10.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 AbbVie Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AbbVie Recent Developments
11.11 LEO Pharma
11.11.1 LEO Pharma Company Information
11.11.2 LEO Pharma Overview
11.11.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 LEO Pharma Recent Developments
11.12 Biogen
11.12.1 Biogen Company Information
11.12.2 Biogen Overview
11.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Biogen Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Biogen Recent Developments
11.13 Galectin Therapeutics
11.13.1 Galectin Therapeutics Company Information
11.13.2 Galectin Therapeutics Overview
11.13.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Galectin Therapeutics Recent Developments
11.14 Cellceutix
11.14.1 Cellceutix Company Information
11.14.2 Cellceutix Overview
11.14.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Cellceutix Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Cellceutix Recent Developments
11.15 Bayer
11.15.1 Bayer Company Information
11.15.2 Bayer Overview
11.15.3 Bayer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Bayer Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Bayer Recent Developments
11.16 Organon
11.16.1 Organon Company Information
11.16.2 Organon Overview
11.16.3 Organon Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Organon Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Organon Recent Developments
11.17 UCB
11.17.1 UCB Company Information
11.17.2 UCB Overview
11.17.3 UCB Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 UCB Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 UCB Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plaque Psoriasis Treatment Medications Industry Chain Analysis
12.2 Plaque Psoriasis Treatment Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plaque Psoriasis Treatment Medications Production Mode & Process
12.4 Plaque Psoriasis Treatment Medications Sales and Marketing
12.4.1 Plaque Psoriasis Treatment Medications Sales Channels
12.4.2 Plaque Psoriasis Treatment Medications Distributors
12.5 Plaque Psoriasis Treatment Medications Customers
13 Plaque Psoriasis Treatment Medications Market Dynamics
13.1 Plaque Psoriasis Treatment Medications Industry Trends
13.2 Plaque Psoriasis Treatment Medications Market Drivers
13.3 Plaque Psoriasis Treatment Medications Market Challenges
13.4 Plaque Psoriasis Treatment Medications Market Restraints
14 Key Findings in the Global Plaque Psoriasis Treatment Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer